Waters Company at the moment introduced that it has acquired Halo Labs™, an innovator of specialised imaging applied sciences to detect, establish, and depend interfering supplies (particles) in therapeutic merchandise, corresponding to cell, protein, and gene therapies.
The Aura™ platform from Halo Labs includes a extremely differentiated expertise that performs full spectrum particle evaluation and is complementary to the Waters mild scattering detection options from its Wyatt Know-how™ Portfolio. For instance, its subvisible particle expertise unlocks further insights when characterizing exterior particles used to amplify CAR T-cells for cell remedy, detecting these translucent course of impurities which might be at the moment undetectable by normal strategies. By buying this revolutionary firm, Waters will be capable of combine this rising expertise into new and current massive molecule improvement and QA/QC, giving a key value-add to prospects whereas accelerating the Firm’s progress into analytical and bioprocessing testing for big molecule therapies.
Including the revolutionary low-sample-volume, high-throughput expertise from Halo Labs offers evaluation for a broad vary of pattern varieties and volumes, enabling earlier insights throughout remedy improvement and better security throughout manufacturing,”
Dr. Udit Batra, President and Chief Government Officer, Waters Company
“With the fast progress of therapies like CAR T-cell therapies, we’re investing within the innovation our prospects want. Along with our current Wyatt Know-how product traces, this acquisition enhances our management place in specialised analytical applied sciences for rising biopharma therapies.”
“We’re thrilled to hitch forces with Waters, an organization that shares our values of purposeful innovation and buyer focus,” mentioned Rick Gordon, Chief Government Officer, Halo Labs. “This mixture accelerates our imaginative and prescient to broaden our platform’s attain, enhancing therapeutic improvement and manufacturing whereas sustaining our unwavering dedication to drug high quality and security. We look ahead to driving extra groundbreaking developments that profit sufferers worldwide.”
Right now’s acquisition of Halo Labs is predicted to have a negligible impression on the Firm’s revenue assertion over the next 12 months.